Dx developer Singulex files $86.25M IPO; Ex-Orthofix manager charged with health care fraud;

 @FierceMedDev: Terumo renewed its license of some crucial stent tech from Biosensors International. More | Follow @FierceMedDev

 @MarkHFierce: An FDA panel supports approval for Second Sight's retinal prosthesis. More | Follow @MarkHFierce

 @DamianFierce: API producer Cedarsburg Hauser is expanding its capabilities and betting on a boom in CMO demand. More | Follow @DamianFierce

> California diagnostics developer Singulex has filed for an $86.25 million IPO. The San Francisco Business Times reports that the company is also promising a test to measure heart disease at levels that weren't possible before. Story

> What does Medtronic's ($MDT) buyout of China Kanghui Holdings mean for other devicemakers trying to get a foothold in China? Report

> ConvaTec has closed its $321 million acquisition of catheter-maker 180 Medical. News

> California's LoneStar Heart has enrolled its first patient in a worldwide safety and efficacy test for Algisyl-LVR, an implantable biopolymer to treat heart failure. Release

> Covidien ($COV) is showcasing its Sonicision cordless ultrasonic dissection device and iDrive Ultra powered stapling system at the annual American College of Surgeons convention in Chicago. More

> SafeStitch Medical has begun shipping its new hernia fixation device, four months after its initial commercial launch. Release

> A former territory manager for Orthofix has been charged with health-care fraud regarding an alleged scheme to submit $250,000 in fraudulent claims for bone-growth stimulator devices that fell short of Medicare guidelines. Story

Biotech News

 @FierceBiotech: TDM-1's impressive survival rate puts Roche and Genentech on track for FDA approval. More | Follow @FierceBiotech

 @JohnCFierce: MIT finance wiz calls for $30B megafund to back next-gen cancer drugs. More | Follow @JohnCFierce

 @RyanMFierce: Amid hunt for partnerships, AstraZeneca hits the blogosphere with LabTalk. More | Follow @RyanMFierce

> Ariad grabs spotlight at ESMO with 'compelling' results for lung cancer drug. Article

> Bayer, Evotec join forces on $765M endometriosis drug partnership. Item

> MIT financial wiz calls for $30B megafund to back next-gen cancer drugs. Story

Pharma News

@FiercePharma: In Europe, J&J's injectable wins approval + gets AML-in-elderly use. More | Follow @FiercePharma

> Herceptin data fends off $1.5B threat to Roche sales. News

> Abbott exec can take comfort in Mylan CEO's degree travails. Article

> Pfizer's Xalkori, Roche's TDM-1 among winners at ESMO. Story

CRO News

> Quintiles considering small acquisitions, CEO says. News

> FDA taps CRO Vince & Associates for $5M bioequivalent contract. Story

> FDA now in charge of clinical trial transparency. Article

> Cedarburg Hauser bets on API boom with plant expansion. Item

Biotech IT News

> AstraZeneca hits the blogosphere with LabTalk. Story

> Genomics outfit puts genetic tests on computers. News

> ChemAxon opens shop in 'heart' of Boston biotech hub. Article

> Medidata advances clinical trials software use in Japan. Item


Suggested Articles

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.

The company describes the continuous glucose monitor as the world’s smallest and thinnest diabetes sensor, with a disc about the size of two pennies.